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Abstract.  A  novel form of protein-saccharide linkage 
consisting of single N-acetylglucosamine (GIcNAc) 
residues attached in O-linkages directly to the poly- 
peptide backbone has been described (Holt, G.  D., 
and G. W.  Hart,  1986, J.  Biol.  Chem.,  261:8049- 
8057).  This modification was found on proteins dis- 
tributed throughout the cell, although proteins bearing 
O-linked GIcNAc moieties were particularly abundant 
in the cytosolic and nuclear envelope fractions of rat 
liver.  In the accompanying article (Snow,  C.  M., A. 
Senior, and L.  Gerace,  1987, J.  Cell. Biol.,  104: 
1143-1156), the authors describe monoclonal anti- 
bodies directed against eight proteins localized to the 
nuclear pore complex. These proteins occur on the 
cytoplasmic and nucleoplasmic (but not lumenal)  sides 
of nuclear membranes.  In this report,  we demonstrate 
that all members of this group of pore complex pro- 
teins bear multiple O-linked GIcNAc residues.  Further, 
we show that the O-linked GIcNAc moieties are linked 
via serine (and possibly threonine)  side chains to these 
proteins.  Perturbing the O-linked GIcNAc residues ei- 
ther by covalently attaching galactose to them or by 
releasing them with 13-N-acetylglucosaminidase 
strongly diminishes the immunoreactivity of the pro- 
teins with all of the monoclonal antibodies.  However, 
the O-linked GIcNAc moieties are only part of the epi- 
topes recognized,  since O-GlcNAc-containing limit 
pronase fragments of nuclear pore complex proteins 
cannot be immunoprecipitated by these antibodies. 
These findings,  taken together with those in the ac- 
companying article,  are a direct demonstration that 
proteins of the cytoplasm and nucleoplasm bear 
O-linked GIcNAc residues. 
p 
REVAILING evidence suggests that the bulk of the well- 
studied types of carbohydrate  moieties on glycocon- 
jugates  are  either  localized  to  the  cell  surface  or 
within  lumenal  compartments  of intracellular  organelles 
(e.g.,  lysosomes,  Golgi,  and  endoplasmic  reticulum).  In 
contrast,  relatively little evidence has been obtained suggest- 
ing  the existence  of glycoproteins in the cytoplasmic  and 
nucleoplasmic compartments of cells.  Early studies  involv- 
ing carbohydrate analyses of nuclei and nuclear matrix frac- 
tions indicated the presence of glycoconjugates in these frac- 
tions  (reviewed  in Furukawa and Terayanm,  1979; Stein et 
al.,  1981; Stoddart,  1979), and the presence of cytoplasmic 
glycoproteins  has also been suggested  (Meyer and Burger, 
1976). These data have received support in several more re- 
cent  investigations  (e.g.,  Kan  and  Pinto  da  Silva,  1986; 
Fedarko and Conrad,  1986; Nagakura  et al.,  1986). How- 
ever, attempts to identify and characterize  nucleoplasmic and 
cytoplasmic  glycoproteins have been severely hampered by 
cross-contamination  with other cellular compartments,  and 
detailed biochemical analyses of most putative cytoplasmic 
and nucleoplasmic glycoproteins  is lacking. 
Recently the subcellular distribution of glycoproteins bear- 
ing terminal  N-acetylglucosamine (GIcNAc) ~ residues was 
surveyed  (Holt and Hart,  1986) by employing  galactosyl- 
transferase, an enzyme that transfers galactose residues from 
a high energy sugar donor to virtually any terminal  GlcNAc 
moiety (Brew et al.,  1968), to specifically  label glycopro- 
teins present in subcellular fractions of rat liver. It was dem- 
onstrated that while most subcellular fractions  contain dis- 
tinctive  groups of proteins beating  O-linked  GIcNAc,  the 
bulk of the proteins bearing this linkage are in the cytosol and 
nuclear  envelopes.  A  62-kD  protein  of the  nuclear  pore 
complex that binds wheat germ agglutinin was recently de- 
scribed (Davis and Blobel, 1986), and was suggested to be 
an O-linked  GlcNAc-bearing  protein. 
In the accompanying  paper,  Snow et al. (1987) describe a 
set of monoclonal antibodies that bind to different members 
of a group of eight structurally distinct proteins of the nuclear 
pore complex that share common epitopes.  By immunoelec- 
tron microscopy performed on isolated nuclear envelopes, it 
was found that the proteins recognized by the monoclonal an- 
tibodies occur on the cytoplasmic and nucleoplasmic (but not 
1.  Abbreviations  used  in  this paper:  GalNAc,  ~N-acetylgalactosamine; 
GIcNAc, lYN-acetylglucosamine. 
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proteins and the epitopes recognized by these monoclonal 
antibodies are characterized further. We demonstrate that the 
proteins have multiple sites of O-linked GlcNAc addition, 
and  that  these  residues  are  attached  to  protein  via  the 
hydroxyl side chains of serine (and possibly threonine). In 
addition, our data strongly suggest that O-linked GlcNAc 
moieties are part of the epitopes recognized by all of the 
monoclonal antibodies described.  These data demonstrate 
the existence of a specific form of glycosylation, O-linked 
GIcNAc,  which occurs on proteins in the cytoplasmic and 
nucleoplasmic compartments of the cell. 
Materials and Methods 
Nuclear Envelope  Preparation and Labeling 
Nuclear envelopes were prepared as described (Dwyer and Blobel,  1976; 
Gerace et al.,  1982).  The fraction of nuclear envelopes used in the experi- 
ments presented here corresponded to the D2P fraction as defined by these 
authors. The following manipulations were performed either with ice-cold 
reagents or at 4"C unless noted. In some experiments, nuclear envelopes 
were prewashed with 0.5 M NaC1 (as described in the accompanying paper, 
Snow et al.,  1987) before labeling when it was desirable to remove con- 
taminating  chromatin.  Labeling  of  the  nuclear  envelopes  with  galac- 
tosyltransferase was performed by a modification of a previously described 
technique (Holt and Hart,  1986).  Nuclear envelopes were solubilized at a 
ratio of 100 U (1 U of nuclear envelopes is the amount derived from 1 A260 
U of isolated rat liver nuclei containing 3  x  106 nuclei) per 100 Ixl of 2% 
Triton X-100, 0.5 M NaC1, and 50 mM Hepes, pH 6.8 (buffer H). The solu- 
bilized nuclear envelopes were stored on ice for 60 rain and were subjected 
to occasional bursts of sonication to fully disrupt the sample. Insoluble ma- 
terial was removed by subjecting the samples to microcentrifugation for 4 
rain at 4°C. The supernatant was transferred to a second tube containing 6 
I~1 of 100 mM Hepes, pH 7.3,  100 mM galactose, 50 mM MnC12, 2.5% 
Nonidet P-40, and 10% Aprotinin (Sigma Chemical Co., St.  Louis, MO) 
per 100 U. Bovine colostrum galactosyltransferase (Sigma Chemical Co.), 
which had been previously auto-galactosylated as described (Holt and Hart, 
1986) was added to the nuclear envelopes at a ratio of 175 mU per 100 U 
except where noted.  Labeling was initiated with the addition of 5  ~tl of 
1 mCi/ml of uridine 5'-diphospho-[3H]galactose (Amersham Corp., Arling- 
ton Heights, IL) in 25 mM 5'-AMP. The specific activity of the radiolabeled 
sugar donor was 17.3 Ci/mmol or, if limit labeling of the sites of galactosyla- 
tion was desired, the specific activity was adjusted to 1.73 Ci/mmol by add- 
ing the appropriate amount of cold uridine 5'-diphosphogalactose (Sigma 
Chemical Co.). Labeling proceeded for 30 rain at 37°C unless noted, and 
then the reaction was terminated by bringing the solution to 50 mM EDTA. 
Using labeling conditions in which no cold uridine 5'-diphosphogalactose 
is added to the reaction mixture, we found that only a  small percentage 
(<7-10%, see Results for details) of the possible sites of glycosylation by 
galaetosyltransferase became occupied  by  [3H]galactose.  Protein-incor- 
porated  label  was  separated from unincorporated uridine 5'-diphospho- 
[3H]galactuse by fractionation according to size on columns of Sephadex 
G-50 (1  ×  30 cm) run in 50 mM ammonium formate, 0.1%  SDS, unless 
otherwise noted. Protein labeled in this manner was concentrated by precip- 
itation in 8 vol of acetone at  -20°C for  18 h. 
Monoclonal Antibodies 
Monoclonal antibodies were prepared as described in the accompanying pa- 
per (Snow et al.,  1987).  Antibodies were coupled to cyanogen bromide 
preactivated Sepharose 4B (Sigma Chemical Co.) at 5 mg antibody per ml 
packed beads. Monoclonal antibody-Sepharose conjugates were stored in 
PBS with 0.02% azide and then washed with buffer H immediately before 
use. 
Immunoadsorptions 
The following manipulations were performed either with ice-cold reagents 
or at 40C. Nuclear envelopes were solubilized and cleared of insoluble ma- 
terial in buffer H as described above for galactosyltransferase labeling. The 
solubilized nuclear envelopes were then combined with an amount of im- 
mobilized antibody determined to be in excess of the amount necessary to 
fully clear the solution of its corresponding antigen(s), usually ,',,1130 I.tl of 
packed antibody-Sepharose beads per 3  ×  l0  s nuclear equivalents. The 
nuclear envelope/antibody-Sepharose mixtures were shaken for 18 h, and 
the  supernatants were  removed  after  sedimentation of the  beads  in  a 
microcentrifuge for 7 s. The beads were washed four times with 10 vol of 
buffer H, and then once with 10 vol of 10 mM Tris-HCl, pH 7.4. The im- 
munoadsorbed material was eluted two times by boiling the washed beads 
in 1.5 vol of 0.5% SDS, 50 mM Tris-HCl, pH 7.4. The eluates were then 
pooled and precipitated in 8 vol of acetone at -20°C for further manipula- 
tion or for direct quantitation. 
Competition Experiments 
Nuclear envelopes were labeled as described above such that only a small 
percentage of the possible sites of glycosylation by galactosyltransferase 
were occupied by [3H]galactose.  Labeled proteins were then immunoad- 
sorbed directly from this solution (i.e., with unincorporated label still pres- 
ent) using RL2-Sepharose in the presence of various monosaccharides and 
glycoproteins. Immunoadsorbed materials were washed and eluted as de- 
scribed above, and the quantity of labeled protein bound to the monoclonal 
antibody was determined. For inhibitors of immunoadsorption, I-M solu- 
tions of either GIcNAc or N-acetylgalactosamine (GalNAc) were used, or 
5  mg/ml solutions of either GlcNAc or GalNAc coupled synthetically to 
BSA through ap-aminophenyl linkage (16 and 21 mol carbohydrate per tool 
BSA, respectively; Sigma Chemical Co.). For the latter class of inhibitors 
of immunoadsorption, fatty acid- and globulin-free BSA was used as a con- 
trol inhibitor. 
In a second set of competition experiments, nuclear envelopes were la- 
beled as described above with cold uridine 5'-diphosphogalactose  using one- 
tenth the amount of galactosyltransferase used above. It was necessary to 
reduce the amount of transferase so that the kinetics of galactosylation were 
slow enough to be analyzed. The nuclear envelopes with intermediate levels 
of galactosylation were combined with antibody-Sepharose for immunoad- 
sorption, as described above. 
Hexosaminidase Digestions 
Nuclear envelopes were washed in 10 mM sodium cacodylate, pH 5.0, and 
then suspended at 100 U per 1(30 I~1 of the same buffer. The samples were 
then sonicated briefly.  Protease cocktails Pic 1 and Pic 2 (Holt et al., 1985) 
were added at  1 01/100 I~1 sample. Jack Bean 13-N-acetylglucosaminidase 
(Sigma Chemical Co.) was added at 0.71 U/100 lal sample. Deglycosylation 
was initiated by incubating the samples at 37°C. For time-course experi- 
ments, the reaction was stopped by boiling aliquots for 5  min. For limit 
deglycosylation experiments, the reaction was continued for 22 h and then 
the reaction was stopped by boiling in gel sample buffer (see below). The 
extent of deglycosylation was monitored by radiolabeling the hexosamini- 
dase-treated  nuclear  envelopes  with  galactosyltransferase, as  described 
above. The transfer of [3H]galactose to free GlcNAc released by the hex- 
osaminidase was determined by paper chromatography according to the 
method of Porzig (1978). 
Pronase Digestion of  Nuclear Envelopes 
Nuclear envelopes (3  x  10  s nuclear equivalents) were washed in 0.2 M 
Tris-HC1, pH 7.8,  1.5 mM CaCIe and then suspended in 200  Ix1 of this 
buffer. The solution was brought to 2% final concentration of Triton X-100 
and stirred at room temperature for I h. To this was added 25 Ixl of 10 mg/ml 
Pronase-CB (75,500  proteolytic  units/g;  Calbiochem-Behring Corp.,  La 
Jolla, CA) that had been preincubated for 40 min at 500C in the Tris/Ca 
buffer. The solution was stirred at room temperature for 15 min and then 
incubated without stirring for 20 h at 37°C. Additional Pronase-CB (25 lal) 
was added and the reaction was continued at 37°C for 20 h. The reaction 
was terminated by boiling the solution for 20 rain. Insoluble material was 
removed by pelleting in a microcentrifuge. Portions of the supernatant were 
immunoadsorbed with RL2-Sepharose, as described above. Eluates from 
this immunoadsorption, as  well  as the RL2-Sepharose supernatant and 
nonimmunoadsorbed digests, were labeled with galactosyltransferase, also 
as described above. The products of the labeling were fractionated on Bio- 
Gel P-4 columns (-400 mesh, 1  x  175 cm) at 12 rnl/h in 0.2 M ammonium 
acetate at 50°C. The columns were standardized with GlcNAc polymer stan- 
dards, assayed by the method of Park and Johnson (1949),  and their void 
and included volumes were established by the elution of dextran and galac- 
tose, respectively. 
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in the accompanying paper (Snow et al.,  1987). 
Determination of the Number of  Sites 
of  Glycosylation per Protein 
RL2-immunoadsorbed material from nuclear envelopes was subjected to 
labeling conditions for maximal galactose incorporation as described above. 
The labeled proteins were then separated by SDS PAGE. The resulting gels 
were then fixed and stained with Coomassie Blue according to the method 
of  Fenner et al. (1975) for the quantification of  stained protein. Stained bands 
were cut out from the gel background and the Coomassie Blue bound to the 
proteins was eluted in 25 % aqueous pyridine. Dye elution was spectroscopi- 
cally determined at 605 nm and was compared with BSA standards that were 
run and stained on the same gel. Thus, the moles of protein in a given band 
on the gel from nuclear envelope immunoadsorptions could be calculated. 
Next the gel slices from the immunoadsorptions were subjected to 13-elim- 
ination in a small volume of 0.1  M  NaOH for 24 h at 37°C.  The samples 
were neutralized with dilute HC1 and counted to determine the release of 
[3H]galactose.  Moles of galactose released was calculated from the specific 
activity of the uridine 5'-diphospho-[3H]galactose.  Simple division of moles 
galactose released by moles protein present in a gel slice of the immunoad- 
sorptions gave the ratio of sites of glycosylation per protein molecule. 
Determination of the Site of  Glycosylation 
RL2-immunoadsorbed material from nuclear envelopes was lightly galac- 
tosylated, as described above, and then separated by SDS PAGE. The pro- 
tein(s) migrating with an apparent molecular mass of 63 kD were excised 
and eluted from gel slices (monitored by radioactivity), and precipitated 
by adding 8 vol of acetone at -20°C. The protein was subjected to [3-elim- 
ination in 0.1 M  sodium hydroxide, and 1 mM NaB3I-h (20 mCi,  17.9 Ci/ 
mmol; Amersham Corp.) for 22 h at 37°C. Radiolabeled protein was sepa- 
rated from unincorporated label by fractionation on columns of Sephadex 
G-50 (1  x  30 cm) and precipitated in acetone, as described above. Exchange- 
able hydrogens were cleared from the labeled protein by resuspending the 
precipitated protein in water, incubating the solution for 1 h  at 37°C, and 
then removing the water by lyophilization. This water extraction was re- 
peated five times. The labeled protein was subjected to compositional analy- 
sis according to the Water's Picotag method (Johns Hopkins Protein Se- 
quencing Facility). The radioactivity of  the derivatized amino acids was also 
monitored on fractions of the derivatized samples as they eluted from the 
compositional analysis column. During the l~-elimination,  serine and threo- 
nine residues bearing O-linked glycosides are converted into alanine and 
ot-aminobutyric acid, respectively (Tanaka  and Pigman,  1965). 
Results 
Monoclonal Antibodies Against Nuclear Pore 
Complex Proteins Recognize a Group of  Polypeptides 
Which Are Glycosylated 
The monoclonal antibodies described in the accompanying 
paper (Snow et al.,  1987) react with different subsets of a 
group of eight nuclear pore complex proteins, ranging from 
all eight proteins (RL2) to a single polypeptide (RLll). We 
observed that the set of proteins recognized by RL2 on im- 
munoblots of nuclear envelopes looked strikingly similar to 
the set of nuclear envelope glycoproteins labeled by galac- 
tosyltransferase described before (Holt and Hart,  1986). To 
determine whether the two groups coincide, solubilized nu- 
clear envelopes were combined with RL2-Sepharose and the 
material that was immunoabsorbed was subsequently labeled 
by galactosyltransferase and  uridine  diphospho-[3H]galac  - 
tose. As shown in Fig.  1, the material immunoabsorbed by 
RL2 serves as an excellent substrate for galactosylation. Fur- 
thermore, RL2 immunoabsorbs the entire population of nu- 
clear envelope proteins bearing GlcNAc residues; no detect- 
able galactosylatable material remains in the supernatant of 
a nuclear envelope preparation after it has been cleared by 
Figure 1. Correspondence between nuclear pore proteins immuno- 
reactive  with  the  monoclonal  antibody, RL2,  and  the  proteins 
which  serve  as  substrates  for galactosyltransferase. Solubilized 
nuclear  envelopes were  immunoadsorbed  with  RL2-Sepharose. 
Portions were subjected to differing extents of galactosylation with 
bovine  colostrum  galactosyltransferase and  uridine  diphospho- 
[3H]galactose. These pretreated and untreated portions were sepa- 
rated by SDS PAGE. One lane of the untreated nuclear envelopes 
was transferred to nitrocellulose and subjected to blotting with solu- 
ble RL2 antibody (immunoblotting). (Lane IB) Nuclear envelopes 
immunoblotted with soluble RL2 antibody; (lane CB) immunoad- 
sorbed sample stained with Coomassie Blue;  (lane [31t] L)  im- 
munoadsorbed  sample  galactosylated  only  lightly  (40  pmol 
[3H]galactose incorporated  per  1.5  x  l0  s nuclear  equivalents); 
(lane [3H] I) immunoadsorbed sample galactosylated to an inter- 
mediate extent (105 pmol [3H]galactose  incorporated per 1.5 x  l0  s 
nuclear equivalents). The migration positions of the major glyco- 
proteins are shown (xl0  -3) at the left. In addition, the migration 
positions of molecular mass standards (center,  xl0  -3) are  indi- 
cated. The stars indicate the migration positions of heavy and light 
chains in the Coomassie Blue-stained lane. 
excess RL2-Sepharose (data not shown). The major galac- 
tosylation products of the immunoabsorbed samples are very 
similar in migration to polypeptides detected by RL2 immu- 
noblots (cf. lanes IB and l~H] L  Fig.  1).  However, the in- 
corporation of increasing amounts of [3H]galactose on the 
proteins decreases their mobility during SDS PAGE. For ex- 
ample, the protein(s) normally migrating with an apparent 
mass of  63 kD when lightly labeled are shifted to an apparent 
mass of '~67 kD when heavily labeled. Since >90% of the 
GlcNAc moieties galactosylated on nuclear envelope pro- 
teins consist of single GlcNAc residues attached directly to 
the  polypeptide backbone  in  O-linkages  (Holt  and  Hart, 
1986), these data strongly suggest that the group of nuclear 
pore complex proteins recognized by the monoclonal anti- 
body RL2 all have O-linked GlcNAc residues on them. 
O-Linked GlcNAc Structures Are Attached 
via Serine Side Chains to Nuclear Pore 
Complex Proteins 
The  chemistry  of O-glycosidic linkages  was  exploited in 
order to  determine the  amino  acid  to  which the  GIcNAc 
moieties on these nuclear pore complex glycoproteins are at- 
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Figure 2. O-linked GIcNAc moieties are linked to nuclear pore pro- 
teins via serine side chains. RL2-immunoadsorbed nuclear enve- 
lopes were separated by SDS PAGE. The protein(s) migrating with 
an apparent molecular mass of ,o63 kD on the gel was excised and 
elnted. The protein was then treated in a mild alkali solution with 
tritiated sodium bomhydride. The resultin~ sample was subjected 
to amino acid compositional analysis using the Water's Picotag sys- 
tem. (Top) Amino acid compositional data for the 63-kD protein; 
(bottom) radioactivity elution profile for the same composition ex- 
periment as the top panel. The single letter abbreviations of amino 
acid elution peaks are indicated in both panels, aab, the elution po- 
sition of ¢t-aminobutyrate (the [I-elimination product of threonine 
from which an O-linked carbohydrate was released); Unk, denotes 
peaks eluting with no known amino acid derivative, and probably 
representing radioactive contaminants in the NaB3I-I4, since these 
peaks are not labeled in other experiments. We have observed such 
anomalous peaks in all commercially available preparations of this 
reagent. 
tached. Base-induced cleavage of O-linked glycosides (termed 
P-elimination) in the presence of sodium borohydride results 
in the reduction of the use of the amino acid as the site of 
attachment of the carbohydrate (Tanaka and Pigman,  1965). 
This leads to the production of alanine and ¢t-aminobutyrate 
from serine and threonine, respectively, if these amino acids 
serve as sites of O-linked carbohydrate addition. To deter- 
mine the p-elimination products of the RL2 antigens,  im- 
munoabsorbed proteins were first lightly labeled with galac- 
tosyltransferase and  the  products  were  separated  by SDS 
PAGE. The protein migrating at '~63 kD after light galacto- 
sylation (see Fig.  1) was localized by the presence of [3H]ga- 
lactose and then excised and eluted from the gel. The protein 
was then subjected to IS-elimination  in a mild alkali solution 
(pH  13)  containing NaB3I-I4, and the  resulting  3H-protein 
was subjected to amino acid compositional analysis (Fig. 2). 
As can be seen in this figure, the tritiated reduction product 
of a  p-elimination experiment is largely [3H]alanine.  This 
indicates that  serine serves as the major site of O-linked 
GIcNAc addition in this specific nuclear pore complex pro- 
tein. Since there is a small amount of ct-aminobutyrate in the 
NaB3H4 elimination experiments, the presence of some thre- 
onine linkages may also be supported by these data. 
Table I. Determination of  the Number of  Sites of  O-Linked 
GIcNAc Addition on Proteins lmmunoadsorbed by RL2 
Molecular mass  Galactose/  No.  of 
of protein  protein  determinations 
kD  tool 
180  9.8  +  0.6  2 
100  2.0  +  1.2  3 
63  10.0  +  1.8  3 
RL2-immunoadsorbed samples from nuclear envelopes were subjected to ex- 
haustive  galactosylation  with  galactosyltransferase  and  uridine  diphospho- 
[3H]galactose.  The products were separated by SDS PAGE and the resulting 
gel was stained with Coomassie Blue. The Coomassie Blue dye eluted from gel 
slices of the immunoadsorbed protein bands was determined  and compared 
with a standard curve of dye elution from known concentrations of BSA which 
were also run on the same gels. Thus the pmol protein in a given band of im- 
munoadsorbed sample were measured. The gel slices were then subjected to 
13-elimination in a mild base solution and the amount of [3H]galactose  was de- 
termined.  From the  amount of  [3H]galactose  released,  the  pmol  galactose 
present  was  determined  according  to  the  specific  activity  of  the  uridine 
diphospho-pH]galactose used in  the  labeling.  The  pmol  galactose  released 
were divided by the pmol protein present in the gel slices, giving the number 
of sites of glycosylation per protein. 
Pore Complex Proteins Contain Multiple Sites 
of Glycosylation 
To measure the amount of O-linked GlcNAc on the nuclear 
pore complex glycoproteins, RL2-immunoabsorbed mate- 
rial from nuclear envelopes was subjected to exhaustive ga- 
lactosylation with galactosyltransferase and uridine diphos- 
pho-[3H]galactose.  The  products  were  separated  by  SDS 
PAGE and the resulting gel was stained with Coomassie Blue 
to determine the moles of protein present in individual pro- 
tein bands  (see Materials and Methods and Table I).  The 
gel slices containing protein bands were then subjected to 
p-elimination and the moles of [3H]galactose released was 
determined, permitting an estimation of the number of sites 
of glycosylation per protein. As can be seen in Table I, major 
proteins immunoadsorbed by RL2 appear to have multiple 
sites of GIcNAc addition. The two major proteins migrating 
in the 58-63-kD range of the gel (which are increased in ap- 
parent molecular mass by 2-6 kD when they are extensively 
galactosylated and can no longer be separately resolved; see 
Fig.  1 for example) together have an average of 10 sites of 
O-linked GIcNAc addition per peptide. The 180-kD protein 
also appears to have ~10  sites of glycosylation, while the 
100-kD band has '~2 sites. 
Galactosylation Inhibits the Immunoadsorption 
of  Nuclear Pore Complex Proteins 
Since the monoclonal antibody RL2 immunoadsorbs a group 
of  proteins that all appear to serve as substrates for galactosy- 
lation by  galactosyltransferase (see Fig.  1),  we  examined 
whether the epitope recognized by RL2 contains O-linked 
GIcNAc moieties. First, we attempted to block immunoad- 
sorptions with competing monosaccharides.  It was  found 
that, in comparison with immunoadsorption in the absence 
of inhibitors, RL2 immunoadsorbs 92 and 55 % of the nu- 
clear pore proteins in the presence of 1-M solutions of Gal- 
NAc and GIcNAc, respectively (data not shown). Thus the 
antibody apparently is not directed against the GIcNAc moi- 
eties on the pore complex proteins in a leetin-like fashion, 
since very high concentrations of  monosaccharide poorly in- 
hibit precipitation. This is substantiated by the failure of  neo- 
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Figure 3. Galactosylation of nuclear envelopes blocks the immuno- 
adsorption of nuclear pore proteins by RL2.  Nuclear envelopes 
were subjected to increasing extents of galactosylation as described 
in Fig. 1, and then combined with RL2-Sepharose for immunoad- 
sorption.  The antibody supernatants and pelleted material were 
separated from unincorporated label by fractionation on columns 
of Sephadex G-50, and the total [3H]galactose  on proteins eluting 
in the columns' void volumes was determined. The percent incorpo- 
rated galactose immunoadsorbed  (- - •  - -)  is expressed as  the 
amount of [3H]galactose-labeled  protein immunoadsorbed by RL2- 
Sepharose divided by the total macromolecular label incorporated 
in  protein  at  the  given  time  point.  The  incorporation  curve 
(-- •  --) is expressed as the pmol [3H]galactose  incorporated per 
1.5  x  108 nuclear equivalents. 
glycoproteins (synthetically derived glycoproteins in which 
monosaccharides are chemically coupled to protein) such as 
GIcNAc-BSA and GalNAc-BSA, to block immunoadsorp- 
tion. Greater than 90% of control precipitation by RL2 oc- 
curred in the presence of 5 mg/ml-solutions of  either of these 
neoglycoproteins (data not shown;  GIcNAc-BSA and Gal- 
NAc-BSA have monosaccharide/protein coupling ratios of 
16 and 21, respectively). However, the fact that GlcNAc par- 
tially inhibits the precipitation while GalNAc does not sug- 
gests that RL2's binding to nuclear pore complex proteins 
may include GIcNAc as part of its epitope. 
To further test this possibility, we attempted to block the 
antibody binding by modifying the O-linked GlcNAc moie- 
ties on the proteins with the attachment of galactose. Nuclear 
envelopes were subjected to increasing levels of galactosyla- 
tion by galactosyltransferase and  these  preparations  were 
then immunoadsorbed with RL2-Sepharose. As is shown in 
Fig.  3, there is an inverse relationship between the level of 
galactosylation of nuclear envelope proteins and the relative 
amount of labeled antigen  immunoadsorbed by  RL2.  In- 
terestingly, as the level of galactosylation of nuclear enve- 
lopes approaches saturation, the ability of RL2 to immuno- 
adsorb its antigens is almost totally blocked (see below). 
The different monoclonal antibodies described in the ac- 
companying paper (Snow et al., 1987) which bind to various 
subsets of the eight glycoproteins apparently recognize spa- 
cially separate (and therefore distinct) epitopes on one of the 
proteins. Nevertheless, with all of  the antibodies tested (RL1, 
RL2, RL3, RL4, and RLll), galactosylation of nuclear enve- 
lopes significantly inhibits the immunoadsorption of these 
nuclear pore complex glycoproteins (RL1,  RL2,  and RL3 
shown in Fig. 4, others not shown).  At comparatively low 
levels of galactosylation (Fig. 4, left, lanes L), each antibody 
binds to a set of [3H]galactose-labeled antigens that is very 
similar to the proteins labeled by the antibody on immuno- 
blots (see the accompanying paper). Furthermore, most or 
all of the mass of all relevant labeled antigen is bound to the 
antibodies with this light labeling condition (Fig. 4, left, cf. 
lanes s  and p). As the level of [3H]galactose incorporation 
is increased, the antibodies show markedly decreased effi- 
ciency for immunoabsorbing all of their antigens  (Fig.  4, 
left, lanes I). 
The immunoadsorption of total [3H]galactose-labeled  pro- 
teins was  quantitatively measured for samples subjected to 
light,  intermediate, and limit levels of galactosylation (Fig. 
4, right). Clearly, increasing galactosylation of nuclear enve- 
lopes inhibits immunoadsorption to differing extents for in- 
dividual  antibodies.  RL2  was  the  only antibody of those 
tested whose antigen binding was totally abolished at limit 
galactosylation, although all of the antibodies demonstrated 
significantly decreased abilities to immunoadsorb their re- 
spective subset of glycoproteins. These data taken together 
suggest that O-linked GlcNAc may serve as a portion of the 
epitopes recognized by all of the anti-nuclear pore complex 
antibodies  described.  However, the possibility  that  galac- 
tosylating  this  carbohydrate  introduces  allosteric  effects 
Figure  4.  Galactosylation of 
nuclear envelopes blocks the 
immunoadsorption of nuclear 
pore proteins by many unique 
monoclonal  antibodies.  Nu- 
clear  envelopes  were  galac- 
tosylated and combined with 
Sepharose-immobilized  mono- 
clonal antibodies as described 
in Fig. 3. (Le3~) The antibody 
supernatants (s) and pelleted 
material (p) were then  sepa- 
rated by SDS PAGE. The light 
(L), and intermediate (I) lev- 
els of galactosylation refer to 
incorporation  ratios  of •68 
and  236  pmol  [3H]galactose 
incorporated per 1.5 x  10  s nuclear equivalents, respectively. The migration positions of molecular mass standards (xl0  -3) are indicated. 
(Right) The light, intermediate, and limit extents of galactosylation refer to incorporation ratios of •68,  236, and >700 pmol [3H]galactose 
incorporated per 1.5 ×  108 nuclear equivalents, respectively. The percent of the total labeled protein in each fraction was determined for 
the various antibodies as described in Fig. 3. 
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Figure 5. Hexosaminidase  releases O-linked GlcNAc residues from 
nuclear envelopes.  Nuclear envelopes  were treated  with  13-N-ace- 
tylglycosaminidase for increasing  lengths  of time.  The release  of 
free GlcNAc moieties was monitored by galactosylating  aliquots of 
the  digests,  and  then determining  the  amount of [3H]-N-acetyl- 
lactosamine  generated  by paper  chromatography.  In this  figure, 
100% of the total GIcNAc is the amount of GIcNAc present  both 
still bound to protein and released as free GIcNAc in the 22-h time- 
point aliquot. 
which block immunoadsorption cannot be excluded by these 
data alone. 
Hexosaminidase Digestion Prevents Binding of  Anti- 
Nuclear Pore Complex Antibodies to Antigen 
To  further  investigate  the  involvement  of  the  O-linked 
GlcNAc moieties in the binding of the various anti-nuclear 
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Figure 7. Anti-nuclear pore antibodies  require extensive primary 
structure  for immunoadsorption.  Nuclear envelopes  were treated 
exhaustively  with pronase.  Portions of the digest were subjected to 
immunoadsorption with RL2-Sepharose.  Unabsorbed digest  (A), 
RL2 precipitate  (B),  RL2 supernatant  (C) and a mock elution  of 
RL2-Sepharose (D) were each galactosylated  with galactosyltrans- 
ferase  and uridine diphospho-[3H]galactose.  The products of this 
reaction were fractionated on columns of Bit-Gel P-4 (-400 mesh, 
1 ×  175 cm). The numbered arrows at the top of each column show 
the K~v for elution  of chitin standards  composed of a polymer of 
the indicated number of GlcNAc residues.  The large arrowhead in 
D indicates the K~ for elution of uridine diphospho-[3H]galactose. 
The  I~v's  for  elution  of dextran  (,040  kD  apparent  molecular 
mass)  and galactose  are 0 and  1, respectively. 
Figure 6.  Hexosaminidase  digestion  inhibits  binding of anti-nu- 
clear pore antibodies  to antigens.  Hexosaminidase-treated  (+) or 
mock treated (-) nuclear envelopes were subjected to immunoblot- 
ting, as described in Materials and Methods and Fig. 1, with various 
anti-nuclear pore antibodies.  Assays of the digested  nuclear enve- 
lopes used in this particular experiment  indicate that "092 % of the 
total O-linked  GlcNAc residues  are removed  from the proteins  in 
this fraction.  The digested nuclear envelopes were also blotted with 
RL12 (an anti-nuclear lamin A and C antibody), to show that there 
is no apparent proteolysis  in the treated  fractions,  and with  HA4 
(an  anti-plasma  membrane  marker),  to  show  that  there  is  no 
significant contamination of this membrane in the nuclear envelope 
preparation.  The migration positions of molecular mass standards 
(×10  -3  ) are indicated. 
pore antibodies to their antigens, we examined whether en- 
zymatically removing the O-linked GlcNAc residues inhibits 
antigen recognition on immunoblots.  Treatment of nuclear 
envelopes with 13-N-acetylglucosaminidase for 22 h resulted 
in the cleavage of over 90%  of the GlcNAc residues  from 
protein in these preparations (Fig. 5). On immunoblots, limit 
hexosaminidase-treated  samples  exhibited  greatly  reduced 
reactivity with all of the monoclonal antibodies studied (Fig. 
6).  As in the galactosylation experiments described above, 
limit cleavage inhibited,  to differing extents,  the binding of 
each  antibody to  specific  antigens.  Binding of RL2,  RL4, 
and RLll  are largely abolished,  while binding of RL1 and 
RL3  are  less  inhibited.  The loss of reactivity  after hexos- 
aminidase treatment is not due to proteolysis in these sam- 
pies, since the gel bands labeled in lightly galactosylated nu- 
clear envelopes (data not shown),  as well as lamins A  and 
C (Fig. 6, lanes RL12) are not detectably degraded by incuba- 
tion with 13-N-acetylglucosaminidase for 22 h at 37°C. Taken 
together with the results of the galactosylation experiments 
described above, these data strongly indicate that the O-linked 
GIcNAc residues  on  the  glycoproteins  are  intimately  in- 
volved in antibody binding. 
RL2 Requires Protein Structure for lmmunoadsorption 
As shown above, the interaction of RL2 with its antigens in 
both immunoadsorption and immunoblotting appears to be 
very sensitive to perturbation in the O-linked GIcNAc moie- 
ties  on the  nuclear  pore  complex glycoproteins.  To inves- 
tigate whether protein structure also has an influence on RL2 
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after pronase digestion of the nuclear pore complex glyco- 
proteins. Nuclear envelopes were exhaustively digested with 
pronase, and portions of the pronase digest were directly 
galactosylated (Fig. 7 A) or were immunoadsorbed with RL2 
and then galactosylated (Figure 7, B and C). Exhaustively 
digesting nuclear envelopes with pronase leaves a mixture of 
glycopeptides that are heterogeneous in size when fraction- 
ated on columns of Bio-Gel P4 (Fig. 7 A).  Since most of 
the GlcNAc residues apparently are not reduced to the size 
of single glycosylated  amino acids, the sites of O-linked Glc- 
NAc addition may be clustered such that they protect short 
sequences of intervening amino acids from proteolysis. In- 
terestingly, RL2 is unable to immunoadsorb these pronase- 
resistant peptides, since no material detected by galactosyla- 
tion was  specifically bound to  RL2-Sepharose  compared 
with a control sample (Fig. 7, cf. B and D). These data indi- 
cate that RL2, and by analogy the other antibodies studied, 
require some secondary and/or primary protein structure in 
addition to serine and threonine-linked GlcNAc residues for 
binding their antigens. 
Discussion 
In this report, we have demonstrated that a group of nuclear 
pore complex proteins are all modified by a novel saccharide 
linkage. This glycosylation consists of GlcNAc residues at- 
tached in O-linkages predominantly to serine side chains 
along the polypeptide backbones, as shown by direct chemi- 
cal analyses performed in this and previous papers (Torres 
and Hart,  1984,  and Holt and Hart,  1986). These nuclear 
pore complex glycoproteins have multiple sites of carbohy- 
drate attachment, including some with at least 10 O-linked 
GlcNAc moieties per polypeptide chain. In the accompany- 
ing paper, Snow et al. (1987) demonstrate by EM immuno- 
localization that the epitopes recognized by the monoclonal 
antibodies against these proteins are present on the cytoplas- 
mic and nucleoplasmic surfaces of the nuclear pore com- 
plex. They are not detected on the lumenal sides of nuclear 
membranes. These results taken together show that a specific 
type of protein-carbohydrate linkage, O-linked GlcNAc, is 
present on certain proteins of the nuclear pore complex ex- 
posed to both the cytoplasmic and nucleoplasmic compart- 
ments. 
Perturbing the O-linked GIcNAc moieties on the proteins 
by attaching galactose to  them with  galactosyltransferase 
strongly diminishes the immunoreactivity of these proteins 
with all of the monoclonal antibodies. The simplest interpre- 
tation of these data is that the O-linked GlcNAc moieties are 
actually part of the binding epitope. This is substantiated by 
the fact that binding of all of the antibodies to the glycopro- 
teins on immunoblots is largely abolished by hexosaminidase 
treatment. However,  it is important to note that none of the 
antibodies appears to be solely directed against the GlcNAc 
moieties. The monoclonal antibody RL2, which appears to 
be more sensitive to the integrity of tl~e carbohydrates on the 
nuclear pore proteins than any of the other antibodies tested, 
cannot immunoadsorb limit pronase digest glycopeptides of 
nuclear envelope proteins. Thus, these data argue that RL2, 
and, by analogy, the other monoclonals, recognize O-linked 
GIcNAc  groups  together  with  some adjacent protein  se- 
quence to have high affinity interactions with nuclear pore 
proteins. Extensive tertiary protein structure is not required 
for the epitopes, since all of the antibodies react with SDS- 
denatured proteins on immunoblots. The precise composi- 
tion of these epitopes and their similarity to the sites of at- 
tachment of O-linked GIcNAc will be determined in future 
studies. 
The presence of O-linked GIcNAc moieties on proteins in 
the cytoplasm and nucleoplasm is in stark contrast with the 
prevailing evidence that the bulk of the well-studied types of 
glycosylation are either localized on glycoconjugates at the 
cell surface or within the lumenal compartments of intracel- 
lular organelles (e.g., lysosomes, Golgi, and the endoplas- 
mic reticulum).  Although studies have indicated the exis- 
tence  of glycoconjugates in  the  cytoplasmic  (Meyer and 
Burger,  1976; Nagakura et al., 1986; Davis and Blobel, 1986; 
Jarvis and Butel,  1985) and nucleoplasmic (Furukawa and 
Terayama, 1979; Stein et al.,  1981; Stoddart, 1979; Karl and 
Pinto da Silva,  1986) compartments, none of these studies 
conclusively show whether these glycoconjugates are glyco- 
proteins  or  glycolipids, whether the  glycosylation events 
they undergo occur via N- or O-linkages, or whether the 
glycoconjugates arose  from single or multiple processing 
events. 
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